{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:52:18Z","timestamp":1785311538889,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":205,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["390857198"],"award-info":[{"award-number":["390857198"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.nicl.2023.103484","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T15:04:52Z","timestamp":1690383892000},"page":"103484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Assessment of synaptic loss in mouse models of \u03b2-amyloid and tau pathology using [18F]UCB-H PET imaging"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7139-2345","authenticated-orcid":false,"given":"Letizia","family":"Vogler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ballweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Bohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4349-3277","authenticated-orcid":false,"given":"Nils","family":"Briel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Wind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2668-360X","authenticated-orcid":false,"given":"Melissa","family":"Antons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea H.","family":"Kunze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Gn\u00f6rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz-Josef","family":"Gildehaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlheinz","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bartenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Boening","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle I.","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3839-8398","authenticated-orcid":false,"given":"Andreas","family":"Zwergal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter U.","family":"H\u00f6glinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Herms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9247-2843","authenticated-orcid":false,"given":"Matthias","family":"Brendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.nicl.2023.103484_b0005","doi-asserted-by":"crossref","first-page":"9340","DOI":"10.1523\/JNEUROSCI.22-21-09340.2002","article-title":"Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein","volume":"22","author":"Allen","year":"2002","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.nicl.2023.103484_b0010","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2023.103484_b0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neuroimage.2015.12.044","article-title":"Glucose consumption of inflammatory cells masks metabolic deficits in the brain","volume":"128","author":"Backes","year":"2016","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.nicl.2023.103484_b0020","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00259-019-04461-x","article-title":"In vivo imaging of synaptic loss in Alzheimer's disease with [18F]UCB-H positron emission tomography","volume":"47","author":"Bastin","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"10","key":"10.1016\/j.nicl.2023.103484_b0025","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.3390\/molecules25102303","article-title":"The rise of synaptic density pet imaging","volume":"25","author":"Becker","year":"2020","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.nicl.2023.103484_b0030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/jnen\/60.5.403","article-title":"Cortical synapse loss in progressive supranuclear palsy","volume":"60","author":"Bigio","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nicl.2023.103484_b0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fmed.2019.00071","article-title":"(18)F-FDG-PET in mouse models of alzheimer's disease","volume":"6","author":"Bouter","year":"2019","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.nicl.2023.103484_b0040","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2967\/jnumed.115.167858","article-title":"Glial activation and glucose metabolism in a transgenic amyloid mouse model: a triple-tracer pet study","volume":"57","author":"Brendel","year":"2016","journal-title":"J. Nucl. Med."},{"issue":"4","key":"10.1016\/j.nicl.2023.103484_b0045","first-page":"e12914","article-title":"Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration","volume":"31","author":"Briel","year":"2021","journal-title":"Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration."},{"issue":"4","key":"10.1016\/j.nicl.2023.103484_b0050","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00401-022-02483-8","article-title":"Single-nucleus chromatin accessibility profiling highlights distinct astrocyte signatures in progressive supranuclear palsy and corticobasal degeneration","volume":"144","author":"Briel","year":"2022","journal-title":"Acta Neuropathol."},{"issue":"10","key":"10.1016\/j.nicl.2023.103484_b0055","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jamaneurol.2018.1836","article-title":"Assessing synaptic density in alzheimer disease with synaptic vesicle glycoprotein 2a positron emission tomographic imaging","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"issue":"9","key":"10.1016\/j.nicl.2023.103484_b0060","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1177\/0271678X211004312","article-title":"Comparison of [(11)C]UCB-J and [(18)F]FDG PET in Alzheimer's disease: a tracer kinetic modeling study","volume":"41","author":"Chen","year":"2021","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.nicl.2023.103484_b0065","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-021-02244-6","article-title":"Hippocampal glucose uptake as a surrogate of metabolic change of microglia in Alzheimer's disease","volume":"18","author":"Choi","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nicl.2023.103484_b0070","doi-asserted-by":"crossref","unstructured":"S. Deleye A.-M. Waldron J.C. Richardson M. Schmidt X. Langlois S. Stroobants S. Staelens The Effects of Physiological and Methodological Determinants on 18F-FDG Mouse Brain Imaging Exemplified in a Double Transgenic Alzheimer Model Mol Imaging 15 2016 153601211562491.","DOI":"10.1177\/1536012115624919"},{"issue":"1","key":"10.1016\/j.nicl.2023.103484_b0075","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1212\/WNL.0000000000012969","article-title":"Synaptic damage and its clinical correlates in people with early huntington disease: a pet study","volume":"98","author":"Delva","year":"2022","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.nicl.2023.103484_b0080","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1523\/JNEUROSCI.14-08-05077.1994","article-title":"Dendritic pathology of granule cells in Alzheimer's disease is unrelated to neuritic plaques","volume":"14","author":"Einstein","year":"1994","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.nicl.2023.103484_b0085","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1007\/s12035-022-02793-8","article-title":"Assessment of the in vivo relationship between cerebral hypometabolism, tau deposition, tspo expression, and synaptic density in a tauopathy mouse model: a multi-tracer pet study","volume":"59","author":"Endepols","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.nicl.2023.103484_b0090","doi-asserted-by":"crossref","DOI":"10.1186\/s13550-021-00777-8","article-title":"The pharmacokinetics of [(18)F]UCB-H revisited in the healthy non-human primate brain","volume":"11","author":"Goutal","year":"2021","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.nicl.2023.103484_b0095","unstructured":"Allen Institute for Brain Science. 2004; https:\/\/atlas.brain-map.org\/atlas]. Available from: https:\/\/atlas.brain-map.org\/atlas."},{"issue":"1","key":"10.1016\/j.nicl.2023.103484_b0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"The Lancet Neurology"},{"issue":"4","key":"10.1016\/j.nicl.2023.103484_b0105","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nicl.2023.103484_b0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1196\/annals.1332.006","article-title":"Microglia as a potential bridge between the amyloid beta-peptide and tau","volume":"1035","author":"Kitazawa","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"45","key":"10.1016\/j.nicl.2023.103484_b0115","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1523\/JNEUROSCI.3432-04.2004","article-title":"Synaptic targeting by Alzheimer's-related amyloid beta oligomers","volume":"24","author":"Lacor","year":"2004","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.nicl.2023.103484_b0120","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease","volume":"27","author":"Lacor","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nicl.2023.103484_b0125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-6-39","article-title":"Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice","volume":"6","author":"Lasagna-Reeves","year":"2011","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.nicl.2023.103484_b0130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrneurol.2009.219","article-title":"Can Alzheimer disease be prevented by amyloid-beta immunotherapy?","volume":"6","author":"Lemere","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.nicl.2023.103484_b0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.nicl.2023.103484_b0140","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","article-title":"Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects","volume":"10","author":"Logan","year":"1990","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"2","key":"10.1016\/j.nicl.2023.103484_b0145","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.nicl.2023.103484_b0150","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.neuroscience.2005.07.014","article-title":"A three-dimensional digital atlas database of the adult C57BL\/6J mouse brain by magnetic resonance microscopy","volume":"135","author":"Ma","year":"2005","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.nicl.2023.103484_b0155","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2967\/jnumed.115.168179","article-title":"Synthesis and preclinical evaluation of 11c-ucb-j as a pet tracer for imaging the synaptic vesicle glycoprotein 2a in the brain","volume":"57","author":"Nabulsi","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nicl.2023.103484_b0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fnins.2016.00045","article-title":"Automated spatial brain normalization and hindbrain white matter reference tissue give improved [(18)f]-florbetaben pet quantitation in alzheimer's model mice","volume":"10","author":"Overhoff","year":"2016","journal-title":"Front. Neurosci."},{"issue":"1-2","key":"10.1016\/j.nicl.2023.103484_b0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000170884","article-title":"Expression of transgenic APP mRNA is the key determinant for beta-amyloid deposition in PS2APP transgenic mice","volume":"6","author":"Ozmen","year":"2009","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.nicl.2023.103484_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.864514","article-title":"Synaptic vesicle glycoprotein 2a: features and functions","volume":"16","author":"Rossi","year":"2022","journal-title":"Front. Neurosci."},{"issue":"10","key":"10.1016\/j.nicl.2023.103484_b0175","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","article-title":"Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment","volume":"27","author":"Scheff","year":"2006","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.nicl.2023.103484_b0180","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s11307-018-1301-0","article-title":"Quantification of [(18)F]UCB-H binding in the rat brain: from kinetic modelling to standardised uptake value","volume":"21","author":"Serrano","year":"2019","journal-title":"Mol. Imag. Biol."},{"issue":"4","key":"10.1016\/j.nicl.2023.103484_b0185","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrneurol.2018.9","article-title":"Imaging tau and amyloid-\u03b2 proteinopathies in Alzheimer disease and other conditions","volume":"14","author":"Villemagne","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nicl.2023.103484_b0190","doi-asserted-by":"crossref","unstructured":"X. Xiang et al. Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases Sci Transl Med 13 615 2021 p. eabe5640.","DOI":"10.1126\/scitranslmed.abe5640"},{"key":"10.1016\/j.nicl.2023.103484_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.118302","article-title":"In vivo imaging of synaptic density with [(11)C]UCB-J PET in two mouse models of neurodegenerative disease","volume":"239","author":"Xiong","year":"2021","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.nicl.2023.103484_b0200","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.nicl.2023.103484_b0205","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nn.4492","article-title":"[(18)F]FDG PET signal is driven by astroglial glutamate transport","volume":"20","author":"Zimmer","year":"2017","journal-title":"Nat. Neurosci."}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158223001754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158223001754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:44:07Z","timestamp":1778852647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158223001754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":41,"alternative-id":["S2213158223001754"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2023.103484","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of synaptic loss in mouse models of \u03b2-amyloid and tau pathology using [18F]UCB-H PET imaging","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2023.103484","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103484"}}